Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse reaction in the UK
AstraZeneca has announced that their joint study with Oxford University has been ‘paused’ due to a suspected adverse effect which has led to the hospitalisation in one of their patients in the study.
They describe this as ‘routine’, however exactly what this adverse reaction is and the severity of the reaction is unknown.
We do know the patient has been admitted to hospital and we do know this isn’t the first time during the trial a patient has had to be admitted to hospital.
The study will be restarted once the medical regulator gives the go ahead, but for not the trials have been placed on hold.
A final decision on restarting the trial will be taken by the medical regulator the MHRA, which could take only days. But until then all international vaccination sites, in the UK, Brazil, South Africa and the USA are on hold. – BBC NEWS
Both the manufacturers and the media are of course playing down this latest development, but when you consider the relatively small study groups being used in these trials and already the fact that two people have been hospitalised, we really have to question, just how safe is this vaccine?
As soon as we find out more about the exact condition of the patient involved we will let you know.
Please leave your comments below and let us know what you think about this latest development.